By Sulaiman Abdur-Rahman | November 18, 2024
The Health Resources and Services Administration has “invoked the nuclear option of removal from not only the 340B program but also Medicaid and Medicare Part B if manufacturers implement a cash replenishment model,” counsel for Eli Lilly—the manufacturer of Mounjaro, Trulicity and other treatments for weight loss or diabetes—alleged in their complaint.
By Sulaiman Abdur-Rahman | November 12, 2024
U.S. District Senior Judge Beryl A. Howell ruled that federal law “precludes the exercise of jurisdiction to review the agency’s classification of certain oral-only drugs as ‘renal dialysis services’ and its decision to identify [Ardelyx Inc.’s drug Xphozah] as qualifying for such classification.”
By Adolfo Pesquera | November 8, 2024
"This unlawful parole scheme would have rewarded more than 1 million illegal aliens with citizenship and incentivized millions more to break into our country," Texas Attorney General Ken Paxton said.
By Jimmy Hoover | November 6, 2024
Justice Samuel Alito Jr. hypothesized a manufacturing plant which warned that a future fire could pose a threat to its business. Would the business have to then disclose that such a fire had already occurred?
By Jimmy Hoover | November 6, 2024
If asked about alliances between Supreme Court justices, few would put the names Elena Kagan and Samuel Alito Jr. in the same sentence.
By Sulaiman Abdur-Rahman | November 5, 2024
Wiley Rein partner Stephen Obermeier said U.S. District Judge Randolph Moss "made the right decision" to deny a Democratic Congressional Campaign Committee motion seeking preliminary injunctive relief in a lawsuit accusing Republicans of campaign spending violations.
By Avalon Zoppo | November 5, 2024
Judges said the court could turn to the statute's legislative history and other avenues to uphold the regulation even with Chevron deference gone.
By Jimmy Hoover | November 4, 2024
Pierre Riley has insisted throughout the deportation process that he, if returned to his home country, would likely be killed by a former police officer now operating as a drug kingpin.
By Jimmy Hoover | November 4, 2024
The case deals with a whistleblower's claims that a Milwaukee-based unit of telecom giant AT&T routinely overbilled schools and libraries for telecommunications services.
By Sulaiman Abdur-Rahman | November 1, 2024
"The FDA's approval of Lumryz was not arbitrary or capricious," U.S. District Judge Amit P. Mehta wrote in a memorandum opinion favoring Latham & Watkins and rejecting arguments made by Sidley Austin in this dispute.
Presented by BigVoodoo
Join the industry's top owners, investors, developers, brokers and financiers for the real estate healthcare event of the year!
This event shines a spotlight on how individuals and firms are changing the investment advisory industry where it matters most.
This conference aims to help insurers and litigators better manage complex claims and litigation.
SENIOR ASSOCIATE ATTORNEY, BOUTIQUE LAW FIRM, CORPORATE LAW We provide strategic advisory and legal services to the world's leading archite...
We are seeking two attorneys with a minimum of two to three years of experience to join our prominent and thriving education law practice in...